Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure

International Journal of Cardiology

Volumn 109, Issue 2, 2006, Pages 179-187

  Toth, Michael J ^a   Ades, Philip A ^a   Tischler, Marc D ^a   Tracy, Russell P ^a   LeWinter, Martin M ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiac cachexia; Cytokines; Exercise intolerance; Muscle atrophy

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR II; UNCLASSIFIED DRUG;

ADULT; AEROBIC CAPACITY; AGED; ARM WEAKNESS; ARTICLE; CARDIAC PATIENT; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FOREARM; FUNCTIONAL ASSESSMENT; HEART FAILURE; HUMAN; IMMUNE RESPONSE; LEG MUSCLE; MALE; MEASUREMENT; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE STRENGTH; MUSCLE WEAKNESS; PATIENT ASSESSMENT; PHYSICAL CAPACITY; POPULATION RESEARCH; PRIORITY JOURNAL; SKELETAL MUSCLE; STATISTICAL ANALYSIS;

AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BODY COMPOSITION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHRONIC DISEASE; EXERCISE; EXERCISE TOLERANCE; HEART FAILURE, CONGESTIVE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; KNEE; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SKELETAL; RECEPTORS, INTERLEUKIN-6; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33646118754     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.06.006     Document Type: Article

References (42)

1. Levine B., Kalman J., Mayer L., Fillit H.M., and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 322 (1989) 236-241
2. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J.B., and Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report of the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 27 (1996) 1201-1206
3. Testa M., Yeh M., Lee P., et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 28 (1996) 964-971
4. Bradham W.S., Bozkurt B., Gunasinghe H., Mann D.L., and Spinale F.G. Tumor necrosis factoralpha and myocardial remodeling in progression of heart failure: a current prospective. Cardiovasc Res 53 (2002) 822-830
5. Mann D.L. Inflammatory mediators and the failing heart: past, present and the foreseeable future. Circ Res 91 (2002) 988-998
6. Reid M.B., and Li Y.P. Tumor necrosis factor-alpha and muscle wasting: a cellular perspective. Respir Res 2 (2001) 269-272
7. Lang C.H., Frost R.A., Nairn A.C., MacLean D.A., and Vary T.C. TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am J Physiol 282 (2001) E336-E347
8. Alloatti G., Penna C., Mariano F., and Camussi G. Role of NO and PAF in the impairment of skeletal muscle contractility induced by TNF-alpha. Am J Physiol 279 (2000) R2156-R2163
9. Reid M.B., Lannergren J., and Westerblad H. Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha. Involvement of myofilaments. Am J Respir Crit Care Med 166 (2002) 479-484
10. Toth M.J., Matthews D.E., Ades P.A., et al. Skeletal muscle myofibrillar protein metabolism in heart failure: relationship to immune activation and functional capacity. Am J Physiol 288 (2005) E685-E692
11. Macy E.M., Hayes T.E., and Tracy R.P. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 43 (1997) 52-58
12. Heymsfield S.B., Smith R., Aulet M., et al. Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr 52 (1990) 214-218
13. Toth M.J., Gottlieb S.S., Fisher M.L., and Poehlman E.T. Skeletal muscle atrophy and peak oxygen consumption in heart failure. Am J Cardiol 79 (1997) 1267-1269
14. Harrington D., and Coats A.J. Skeletal muscle abnormalities and evidence for their role in symptom generation in chronic heart failure. Eur Heart J 18 (1997) 1865-1872
15. Harrington D., Anker S., Chua T.P., et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 30 (1997) 1758-1764
16. Magnusson G., Isberg B., Karlberg K.-E., and Sylven C. Skeletal muscle strength and endurance in chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 73 (1994) 307-309
17. Reiken S., Lacampagne A., Zhou H., et al. PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle: defective regulation in heart failure. J Cell Biol 160 (2003) 919-928
18. 2+ transients in isolated bundles of skeletal muscle fibers from rats with chronic heart failure. Circ Res 73 (1993) 405-412
19. Ward C.W., Reiken S., Marks A.R., Marty I., Vassort G., and Lacampagne A. Defects in ryanodine receptor calcium release in skeletal muscle from post-myocardial infarct rats. FASEB J 17 (2003) 1517-1519
20. Marx S.O., Reiken S., Hisamatsu Y., et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101 (2000) 365-376
21. Gomez A.M., Valdivia H.H., Cheng H., et al. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 276 (1997) 800-806
22. Dibbs Z., Thornby J., White B.G., and Mann D.L. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J Am Coll Cardiol 33 (1999) 1935-1942
23. Munger M.A., Johnson B., Amber I.J., Callahan K.S., and Gilbert E.M. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 77 (1996) 723-727
24. Anker S.D., Clark A.L., Kemp M., et al. Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J Am Coll Cardiol 30 (1997) 997-1001
25. Lommi J., Pulkki K., Koskinen P., et al. Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure. Eur Heart J 18 (1997) 1620-1625
26. Dutka D.P., Elborn J.S., Delamere F., Shale D.J., and Morris G.K. Tumour necrosis factor in severe congestive cardiac failure. Br Heart J 70 (1993) 141-143
27. Anker S.D., Chua T.P., Ponikowski P., et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96 (1997) 526-534
28. Anker S.D., Ponikowski P.P., Clark A.L., et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 20 (1999) 683-693
29. McMurray J., Abdullah I., Dargie H.J., and Shapiro D. Increased concentrations of tumor necrosis factor in "cachectic" patients with severe chronic heart failure. Br Med J 66 (1991) 356-358
30. Larsen A.I., Lindal S., Aukrust P., Toft I., Aarsland T., and Dickstein K. Effect of exercise training on skeletal muscle fibre characteristics in men with chronic heart failure. Correlation between skeletal muscle alterations, cytokines and exercise capacity. Int J Cardiol 83 (2002) 25-32
31. Goodman M.N. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol 260 (1991) E727-E730
32. Dalla Libera L., Sabbadini R., Renken C., et al. Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF-alpha and sphingosine. J Mol Cell Cardiol 33 (2001) 1871-1878
33. Persinger R., Janssen-Heininger Y., Wing S.S., Matthews D.E., LeWinter M.M., and Toth M.J. Effect of heart failure on the regulation of skeletal muscle protein synthesis, breakdown and apoptosis. Am J Physiol 284 (2003) E1001-E1008
34. Vaisman N., Schattner A., and Hahn T. Tumor necrosis factor production during starvation. Am J Med 87 (1989) 115
35. Cicoira M., Bolger A.P., Doehner W., et al. High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohumoral activation in chronic heart failure patients. Cytokine 15 (2001) 80-86
36. Wilson J.R., Martin J., and Ferraro N. Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: role of cardiac pump dysfunction as determined by the effect of dobutamine. Am J Cardiol 53 (1984) 1308-1315
37. Katz S.D., Roa R., Berman J.W., et al. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure: relation to nitric oxide-dependent vasodilation in the forearm circulation. Circulation 90 (1994) 12-16
38. Mancini D.M., Eisen H., Kussmaul W., Mull R., Edmunds L.H., and Wilson J.R. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83 (1991) 778-786
39. Visser M., Pahor M., Taaffe D.R., et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol 57 (2002) M326-M332
40. Ferrucci L., Penninx B.W.J.H., Volpato S., et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 50 (2002) 1947-1952
41. Yu X.W., Kennedy R.H., and Liu S.J. JAK2/STAT3, not ERK1/2, mediates interleukin-6-induced activation of inducible nitric-oxide synthase and decrease in contractility of adult ventricular myocytes. J Biol Chem 278 (2003) 16304-16309
42. Funakoshi H., Kubota T., Machida Y., et al. Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factoralpha. Am J Physiol 282 (2002) H2159-H2166